84 participants
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-21
- Start Date:
- 2026-08-21
- Completion:
- 2027-06-17
Conditions
- Alzheimer's Disease
- Healthy Participants
Interventions
- DRUG
No Results Yet